Entities › name
26 headlines · 18 outlets · 2024-02-27 → 2026-10-07 · Wikipedia ↗ · 🔒 Follow
Each year, some 15,000 Americans are diagnosed with glioblastoma, the deadliest form of brain cancer. Only 7% live more than five years but a new vaccine still in development could offer patients more time. NBC’s Anne Thompson reports for TODAY.
– Data showed improvements in an objective measure of impaired eye movement associated with Parkinson’s disease, with a correlation between reductions in LRRK2 cerebrospinal fluid (CSF) biomarkers to these changes in oculomotor function and changes in synaptic biomarkers –
[Capital FM] Nairobi -- The Nairobi Hospital remains open, safe and fully operational following confirmation that a patient treated at the facility had Ebola Virus Disease (EVD), Chief Executive Officer Felix Osano has said.
The Government will fail its pledge to treat urgent cancers within two months of referral in England, Cancer Research UK has warned.
– PADCEV™ (enfortumab vedotin) plus pembrolizumab data highlight durable survival benefit in advanced bladder cancer – – VYLOY™ (zolbetuximab) research reinforces the role of CLDN18.2 in shaping gastric cancer treatment decisions – TOKYO, Oct. 6, 2026 /PRNewswire/ -- Astellas Pharma Inc....
Patients hiding the use of illegal peptides or weight loss jabs before surgery could face "serious" consequences, after a new study reveals an 11-fold risk of regurgitation or aspiration under anaesthetic.
The Cala kIQ Plus System, cleared by FDA earlier this year, is the first and only wearable neuromodulation device for hand tremor that provides multiple therapy modes and adaptive calibration designed to optimize tremor relief and personalize treatment Cala is showcasing the Cala kIQ Plus...
Study to Explore Oral Maintenance Dosing Regimens Following Initial Weight Loss with Subcutaneous VK2735 Monthly and Every-Other-Week Subcutaneous Regimens to also be Evaluated SAN DIEGO, Oct. 6, 2026 /PRNewswire/ -- Viking Therapeutics, Inc. (Viking) (NASDAQ: VKTX), a clinical-stage...
LONDON and NEW YORK, Oct. 06, 2026 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (Nasdaq: OKYO ), a clinical-stage biopharmaceutical company developing investigational therapies for the treatment of neuropathic corneal pain (NCP) and anterior segment eye diseases, today announced first patients enrolled…
Tens of thousands of diabetic Britons are at risk of running out of insulin by the end of the year, experts have warned. Levemir, a daily injection, is set to be discontinued in December.
